To assess the efficacy and safety of pf-06650833, pf-06651600, and tofacitinib alone and in combination in participants with active rheumatoid arthritis with an inadequate response to methotrexate
Condition: Rheumatoid Arthritis Interventions: Drug: PF-06650833; Drug: PF-06651600; Drug: Tofacitinib Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials